SCHEDULE 13G

Company

Inhibitor Therapeutics, Inc.

Filed

July 13, 2005

Accession Number

0001193125-05-141541

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →